Gifrer (Ophthalmic Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Gifrer (Ophthalmic Business) General Information

Description

Provider of ophthalmic antiseptic drugs in Italy. The business division consists of Dacudoses commonly used as an eyewash in case of light conjunctivitis or infections and the collyrium brand Novoptine is an over-the-counter antiseptic collyrium used to treat eye infections and conjunctivitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 8-10 Rue Paul Bert
  • 69153 Décines-Charpieu
  • France
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 8-10 Rue Paul Bert
  • 69153 Décines-Charpieu
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gifrer (Ophthalmic Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gifrer (Ophthalmic Business)‘s full profile, request access.

Request a free trial

Gifrer (Ophthalmic Business) Patents

Gifrer (Ophthalmic Business) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3820577-A1 Alkaline oleo-liniment Inactive 13-Jul-2018
WO-2020012136-A1 Alkaline oleo-liniment Inactive 13-Jul-2018
FR-3083701-A1 Oleo-alkaline liniment Active 13-Jul-2018
FR-3083701-B1 Oleo-alkaline liniment Active 13-Jul-2018
EP-1076555-A1 Pectic preparations used as medicine carrier Inactive 15-May-1998 A61K9/0095
To view Gifrer (Ophthalmic Business)’s complete patent history, request access »

Gifrer (Ophthalmic Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gifrer (Ophthalmic Business)‘s full profile, request access.

Request a free trial

Gifrer (Ophthalmic Business) FAQs

  • Where is Gifrer (Ophthalmic Business) headquartered?

    Gifrer (Ophthalmic Business) is headquartered in Décines-Charpieu, France.

  • What industry is Gifrer (Ophthalmic Business) in?

    Gifrer (Ophthalmic Business)’s primary industry is Buildings and Property.

  • Is Gifrer (Ophthalmic Business) a private or public company?

    Gifrer (Ophthalmic Business) is a Private company.

  • What is Gifrer (Ophthalmic Business)’s current revenue?

    The current revenue for Gifrer (Ophthalmic Business) is .

  • Who are Gifrer (Ophthalmic Business)’s investors?

    Laboratoire Gifrer has invested in Gifrer (Ophthalmic Business).

  • When was Gifrer (Ophthalmic Business) acquired?

    Gifrer (Ophthalmic Business) was acquired on 04-Jul-2019.

  • Who acquired Gifrer (Ophthalmic Business)?

    Gifrer (Ophthalmic Business) was acquired by SIFI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process